Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy
- PMID: 32073399
- PMCID: PMC7056272
- DOI: 10.7554/eLife.48705
Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy
Abstract
Mutations in genes encoding synaptic proteins cause many neurodevelopmental disorders, with the majority affecting postsynaptic apparatuses and much fewer in presynaptic proteins. Syntaxin-binding protein 1 (STXBP1, also known as MUNC18-1) is an essential component of the presynaptic neurotransmitter release machinery. De novo heterozygous pathogenic variants in STXBP1 are among the most frequent causes of neurodevelopmental disorders including intellectual disabilities and epilepsies. These disorders, collectively referred to as STXBP1 encephalopathy, encompass a broad spectrum of neurologic and psychiatric features, but the pathogenesis remains elusive. Here we modeled STXBP1 encephalopathy in mice and found that Stxbp1 haploinsufficiency caused cognitive, psychiatric, and motor dysfunctions, as well as cortical hyperexcitability and seizures. Furthermore, Stxbp1 haploinsufficiency reduced cortical inhibitory neurotransmission via distinct mechanisms from parvalbumin-expressing and somatostatin-expressing interneurons. These results demonstrate that Stxbp1 haploinsufficient mice recapitulate cardinal features of STXBP1 encephalopathy and indicate that GABAergic synaptic dysfunction is likely a crucial contributor to disease pathogenesis.
Keywords: cortical inhibitory interneurons; epilepsy; intellectual disability; mouse; neurobehaviors; neuropsychiatric dysfunctions; neuroscience; synaptic transmission.
© 2020, Chen et al.
Conflict of interest statement
WC, ZC, EC, HC, CL, SH, HC, JK, JM, JT, JS, MX No competing interests declared, HZ Senior Editor, eLife
Figures
Similar articles
-
Microcircuit failure in STXBP1 encephalopathy leads to hyperexcitability.Cell Rep Med. 2023 Dec 19;4(12):101308. doi: 10.1016/j.xcrm.2023.101308. Epub 2023 Dec 11. Cell Rep Med. 2023. PMID: 38086378 Free PMC article.
-
STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies.J Neurochem. 2021 Apr;157(2):165-178. doi: 10.1111/jnc.15120. Epub 2020 Aug 4. J Neurochem. 2021. PMID: 32643187 Free PMC article. Review.
-
GABAergic/Glycinergic and Glutamatergic Neurons Mediate Distinct Neurodevelopmental Phenotypes of STXBP1 Encephalopathy.J Neurosci. 2024 Apr 3;44(14):e1806232024. doi: 10.1523/JNEUROSCI.1806-23.2024. J Neurosci. 2024. PMID: 38360746 Free PMC article.
-
Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy.Brain. 2018 May 1;141(5):1350-1374. doi: 10.1093/brain/awy046. Brain. 2018. PMID: 29538625 Free PMC article.
-
STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy.Neurology. 2016 Mar 8;86(10):954-62. doi: 10.1212/WNL.0000000000002457. Epub 2016 Feb 10. Neurology. 2016. PMID: 26865513 Review.
Cited by
-
The DDHD2-STXBP1 interaction mediates long-term memory via generation of saturated free fatty acids.EMBO J. 2024 Feb;43(4):533-567. doi: 10.1038/s44318-024-00030-7. Epub 2024 Feb 5. EMBO J. 2024. PMID: 38316990 Free PMC article.
-
Microcircuit failure in STXBP1 encephalopathy leads to hyperexcitability.Cell Rep Med. 2023 Dec 19;4(12):101308. doi: 10.1016/j.xcrm.2023.101308. Epub 2023 Dec 11. Cell Rep Med. 2023. PMID: 38086378 Free PMC article.
-
Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder.Epilepsia Open. 2022 Sep;7(3):504-511. doi: 10.1002/epi4.12604. Epub 2022 May 17. Epilepsia Open. 2022. PMID: 35451230 Free PMC article.
-
STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies.J Neurochem. 2021 Apr;157(2):165-178. doi: 10.1111/jnc.15120. Epub 2020 Aug 4. J Neurochem. 2021. PMID: 32643187 Free PMC article. Review.
-
In vivo calcium imaging reveals disordered interictal network dynamics in epileptic stxbp1b zebrafish.iScience. 2021 May 19;24(6):102558. doi: 10.1016/j.isci.2021.102558. eCollection 2021 Jun 25. iScience. 2021. PMID: 34142057 Free PMC article.
References
-
- Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR, Epi4K Consortium, Epilepsy Phenome/Genome Project De novo mutations in epileptic encephalopathies. Nature. 2013;501:217–221. doi: 10.1038/nature12439. - DOI - PMC - PubMed
-
- Baker K, Gordon SL, Grozeva D, van Kogelenberg M, Roberts NY, Pike M, Blair E, Hurles ME, Chong WK, Baldeweg T, Kurian MA, Boyd SG, Cousin MA, Raymond FL. Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling. Journal of Clinical Investigation. 2015;125:1670–1678. doi: 10.1172/JCI79765. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
